Protara Therapeutics Inc (TARA)

Finanzdaten der Protara Therapeutics Inc-Aktie (TARA)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	7.34% 11.85	11.04	10.70	12.14	9.732
Operating Income/Loss	7.34% -11.85	-11.04	-10.70	-12.14	-9.732
Nonoperating Income/Loss	7.80% 0.756	0.82	0.84	0.846	0.687
Income/Loss From Continuing Operations Before Tax	53.72% -11.10	-23.97	-9.86	-11.29	-9.045
Income/Loss From Continuing Operations After Tax	8.55% -11.10	-10.22	-9.86	-11.29	-9.045
Net Income/Loss	8.55% -11.10	-10.22	-9.86	-11.29	-9.045
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	100.87K% 11.42	0.0113	11.35	11.31	11.30
Diluted Average Shares	100.87K% 11.42	0.0113	11.35	11.31	11.30
Basic Earnings Per Share	7.78% -0.97	-0.90	-0.87	-1.00	-0.80
Diluted Earnings Per Share	7.78% -0.97	-0.90	-0.87	-1.00	-0.80
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-